• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
HealthBrainstorm Health

A Holdout on the CVS-Aetna Deal: Brainstorm Health

By
Sy Mukherjee
Sy Mukherjee
Down Arrow Button Icon
By
Sy Mukherjee
Sy Mukherjee
Down Arrow Button Icon
June 4, 2019, 6:56 PM ET

Good afternoon, readers.

The corporate marriage between CVS and Aetna was one of the most significant health care transactions of the past few years. But here’s the thing – it’s not, on the most technical level, done done. Or at the very least, there’s still a notable detractor hanging out there.

The retail pharmacy chain and insurance giant won the feds’ blessings for their mammoth merger last year. However, Judge Richard Leon of the U.S. District Court for the District of Columbia has become something of a gadfly for the firms. And he’s still sticking around to question the merits and potential antitrust concerns raised by the M&A.

Specifically, Leon is questioning the deal’s possible effect on competition in the Medicare Part D prescription drug program. There will be three days of testimony related to the issue in federal court.

This is, to put it lightly, a bit of an awkward situation for all involved, especially since CVS and Aetna have already begun behaving like a merged company (and one with Department of Justice blessings). But it ain’t over till the cloaked judge sings.

Read on for the day’s news.

Sy Mukherjee
@the_sy_guy
sayak.mukherjee@fortune.com

DIGITAL HEALTH

Another day, another massive data breach. Medical testing giant Quest Diagnostics is warning that some 12 million consumers' personal medical and financial information may have been breached via an unauthorized user's access to a third party vendor. The information could potentially include banking, medical, and Social Security data, the company says. “Quest Diagnostics takes this matter very seriously and is committed to the privacy and security of patients’ personal, medical and financial information,” Quest said in an SEC filing. (Fortune)

INDICATIONS

Biopharma has a massive pay gap problem. I've been neglecting to highlight this fantastic report from BioPharma Dive on biopharmaceutical company pay for workers and CEOs. The whole thing is worth reading (the publication took pains to examine the data from a market, employee culture, and representation perspective alike) but here's what stood out to me: "In 2018, more than 90% of CEOs were men. Just 16 of the 194 executives included in this analysis were female." Telling, isn't it? (BioPharma Dive)

THE BIG PICTURE

A new study has a beef with chicken. Diet stories seem to rule the world of "health care internet" and we've got another one to add to the pile. A new study from University of California, San Francisco researchers suggests that "white meat" may be about as bad as the dreaded "red meat"—at least when it comes to elevation in cholesterol levels. There's another side to that, too, though... Not all kinds of cholesterol necessarily mean you'll face cardiovascular and heart problems. But, hey, more to chew on in the diet space. (CNN)

REQUIRED READING

A Majority of Economists Think There Will Be a Recession By the 2020 Election, by Erik Sherman

Tech Companies See Big Opportunity in an 'Undercounted and Underestimated' Africa, by Beth Kowitt

Are Digital Tokens Securities?by Bloomberg

Meet the Woman Who Beat the Jeopardy! Champ, by Chris Morris

Produced by Sy Mukherjee
@the_sy_guy
sayak.mukherjee@fortune.com
Find past coverage. Sign up for other Fortune newsletters.
About the Author
By Sy Mukherjee
See full bioRight Arrow Button Icon

Latest in Health

Best protein lead image
HealthDietary Supplements
The 8 Best Protein Powders of 2025: How to Choose, According to an RD
By Christina SnyderDecember 9, 2025
22 hours ago
Transparent Labs Creatine HMB as best creatine
HealthDietary Supplements
The Best Creatine Supplements of 2025: Tested and Approved
By Christina SnyderDecember 9, 2025
22 hours ago
Jon Rosemberg
CommentaryProductivity
The cult of productivity is killing us
By Jon RosembergDecember 9, 2025
1 day ago
Trump
CommentaryTariffs and trade
AI doctors will be good at science but bad at business, and big talk with little action means even higher drugs prices: 10 healthcare predictions for 2026 from top investors
By Bob Kocher, Bryan Roberts and Siobhan Nolan ManginiDecember 9, 2025
1 day ago
Kevin Kiley
PoliticsElections
‘It absolutely matters politically’: Swing-district Republicans alarmed at spiking health insurance premiums tipping midterms
By Marc Levy, Kevin Freking and The Associated PressDecember 8, 2025
2 days ago
HealthHealth
These toxic wild mushrooms have caused a deadly outbreak of poisoning in California
By The Associated PressDecember 7, 2025
3 days ago

Most Popular

placeholder alt text
Economy
‘Fodder for a recession’: Top economist Mark Zandi warns about so many Americans ‘already living on the financial edge’ in a K-shaped economy 
By Eva RoytburgDecember 9, 2025
19 hours ago
placeholder alt text
Politics
Exclusive: U.S. businesses are getting throttled by the drop in tourism from Canada: 'I can count the number of Canadian visitors on one hand'
By Dave SmithDecember 10, 2025
4 hours ago
placeholder alt text
Success
When David Ellison was 13, his billionaire father Larry bought him a plane. He competed in air shows before leaving it to become a Hollywood executive
By Dave SmithDecember 9, 2025
1 day ago
placeholder alt text
Banking
Jamie Dimon taps Jeff Bezos, Michael Dell, and Ford CEO Jim Farley to advise JPMorgan's $1.5 trillion national security initiative
By Nino PaoliDecember 9, 2025
20 hours ago
placeholder alt text
Uncategorized
Transforming customer support through intelligent AI operations
By Lauren ChomiukNovember 26, 2025
14 days ago
placeholder alt text
Economy
The 'forever layoffs' era hits a recession trigger as corporates sack 1.1 million workers through November
By Nick Lichtenberg and Eva RoytburgDecember 9, 2025
1 day ago
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.